• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

820例连续黑色素瘤患者的痛苦及其决定因素

Distress and Its Determinants in 820 Consecutive Melanoma Patients.

作者信息

Reitmajer Markus, Riedel Petra, Garbe Claus, Schäffeler Norbert, Eigentler Thomas K, Forschner Andrea

机构信息

Department of Dermatology, University Hospital Tuebingen, Tuebingen, Germany.

Department of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Tübingen, Germany.

出版信息

Cancer Med. 2025 Mar;14(6):e70820. doi: 10.1002/cam4.70820.

DOI:10.1002/cam4.70820
PMID:40125560
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11931323/
Abstract

BACKGROUND

Psycho-oncological burden not only affects patients' mental health but can also decrease treatment compliance and impair outcomes. The Distress Thermometer (DT) is a widely used screening tool in real-world medical care for identifying and monitoring psychological distress. Patients with melanoma presenting in oncologic outpatient departments comprise a wide range of characteristics. Although young adults may face challenges related to pivotal life stages, such as career responsibilities or parenting, older adults often contend with mobility issues, preexisting comorbidities, or age-related physical limitations.

METHODS

We conducted a retrospective evaluation of DT data from 820 patients with melanoma treated at our outpatient department between July and September 2016. These patients underwent routine DT screening and completed the associated National Comprehensive Cancer Network (NCCN) Problem List. The study aimed to identify factors influencing DT values above the threshold (≥ 5), further characterizing the patients' complaints according to the NCCN Problem List.

RESULTS

A total of 820 patients with melanoma underwent psycho-oncological screening. More than 40% had DT values above the threshold. Significant factors associated with DT values over the threshold included female gender, younger age, and advanced melanoma stages III-IV. Analysis of the NCCN Problem List revealed complaints such as fear, sleep issues, tingling in hands and feet, feeling swollen, problems at work or school, concerns regarding God, and loss of faith.

CONCLUSION

The results indicate a high need for psycho-oncological support for patients with melanoma. Particular attention should be given to patients with the identified factors that are associated with exceeding the DT threshold.

摘要

背景

心理肿瘤负担不仅会影响患者的心理健康,还会降低治疗依从性并损害治疗效果。苦恼温度计(DT)是现实医疗护理中广泛用于识别和监测心理困扰的筛查工具。在肿瘤门诊就诊的黑色素瘤患者具有广泛的特征。虽然年轻人可能面临与关键人生阶段相关的挑战,如职业责任或育儿问题,但老年人往往要应对行动不便、既有合并症或与年龄相关的身体限制。

方法

我们对2016年7月至9月在我院门诊接受治疗的820例黑色素瘤患者的DT数据进行了回顾性评估。这些患者接受了常规DT筛查,并完成了相关的美国国立综合癌症网络(NCCN)问题清单。该研究旨在确定影响DT值高于阈值(≥5)的因素,并根据NCCN问题清单进一步描述患者的主诉。

结果

共有820例黑色素瘤患者接受了心理肿瘤筛查。超过40%的患者DT值高于阈值。与DT值超过阈值相关的显著因素包括女性、年轻以及黑色素瘤III-IV期。对NCCN问题清单的分析揭示了诸如恐惧、睡眠问题、手脚刺痛、感觉肿胀、工作或学校问题、对上帝的担忧以及失去信仰等主诉。

结论

结果表明黑色素瘤患者对心理肿瘤支持的需求很高。应特别关注具有与超过DT阈值相关的已确定因素的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/684f/11931323/55759fa576a7/CAM4-14-e70820-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/684f/11931323/55759fa576a7/CAM4-14-e70820-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/684f/11931323/55759fa576a7/CAM4-14-e70820-g002.jpg

相似文献

1
Distress and Its Determinants in 820 Consecutive Melanoma Patients.820例连续黑色素瘤患者的痛苦及其决定因素
Cancer Med. 2025 Mar;14(6):e70820. doi: 10.1002/cam4.70820.
2
The need for psycho-oncological support for melanoma patients: Central role of patients' self-evaluation.黑色素瘤患者对心理肿瘤学支持的需求:患者自我评估的核心作用。
Medicine (Baltimore). 2017 Sep;96(37):e7987. doi: 10.1097/MD.0000000000007987.
3
Screening for distress in routine oncological care-a survey in 520 melanoma patients.常规肿瘤护理中的痛苦筛查-520 例黑色素瘤患者的调查。
PLoS One. 2013 Jul 5;8(7):e66800. doi: 10.1371/journal.pone.0066800. Print 2013.
4
The national comprehensive cancer network distress thermometer as a screening tool for the evaluation of quality of life in uveal melanoma patients.国家综合癌症网络痛苦温度计作为葡萄膜黑素瘤患者生活质量评估的筛选工具。
Acta Ophthalmol. 2020 May;98(3):e381-e387. doi: 10.1111/aos.14277. Epub 2019 Oct 25.
5
Validity and feasibility of the Arabic version of distress thermometer for Saudi cancer patients.沙特癌症患者痛苦温度计阿拉伯文版的有效性和可行性。
PLoS One. 2018 Nov 14;13(11):e0207364. doi: 10.1371/journal.pone.0207364. eCollection 2018.
6
[Outpatient psychosocial screening in a skin cancer center: acceptance, psychosocial distress and utilization of support : A post hoc analysis in a quality management program].[皮肤癌中心的门诊心理社会筛查:接受情况、心理社会困扰及支持利用情况:质量管理项目中的事后分析]
Dermatologie (Heidelb). 2024 Aug;75(8):629-639. doi: 10.1007/s00105-024-05347-2. Epub 2024 May 8.
7
Screening for distress, related problems and perceived need for psycho-oncological support in head and neck squamous cell carcinoma (HNSCC) patients: a retrospective cohort study.筛查头颈部鳞状细胞癌(HNSCC)患者的痛苦、相关问题和心理肿瘤学支持需求:一项回顾性队列研究。
BMC Cancer. 2021 Apr 30;21(1):478. doi: 10.1186/s12885-021-08236-2.
8
Patient-Reported Distress in Myelodysplastic Syndromes and Its Association With Clinical Outcomes: A Retrospective Cohort Study.骨髓增生异常综合征患者报告的痛苦及其与临床结局的关系:一项回顾性队列研究。
J Natl Compr Canc Netw. 2018 Mar;16(3):267-273. doi: 10.6004/jnccn.2017.7048.
9
Use of NCCN distress thermometer in cancer genetics patients.NCCN 苦恼温度计在癌症遗传学患者中的应用。
Support Care Cancer. 2025 Apr 26;33(5):423. doi: 10.1007/s00520-025-09473-y.
10
Towards the targeted assessment of relevant problems: Optimization of the distress Thermometer for adult neuro-oncological patients.针对相关问题的针对性评估:成人神经肿瘤患者的痛苦温度计的优化。
Psychooncology. 2020 Dec;29(12):2057-2066. doi: 10.1002/pon.5564. Epub 2020 Oct 16.

本文引用的文献

1
Psychosocial distress and psychosocial resources in couples facing non-melanoma skin cancers and malignant melanoma.面临非黑色素瘤皮肤癌和恶性黑色素瘤的夫妻的心理社会困扰与心理社会资源
J Psychosoc Oncol. 2025;43(2):173-188. doi: 10.1080/07347332.2024.2371344. Epub 2024 Jul 3.
2
Content and Duration of Doctor-Patient Communication in Outpatient Oncology Follow-Up Consultations in China.中国肿瘤门诊随访会诊中医患沟通的内容与时长
Cureus. 2024 Mar 5;16(3):e55597. doi: 10.7759/cureus.55597. eCollection 2024 Mar.
3
Lived Experiences and Fear of Cancer Recurrence Among Survivors of Localized Cutaneous Melanoma.
局限性皮肤黑色素瘤幸存者的生活体验和对癌症复发的恐惧。
JAMA Dermatol. 2024 May 1;160(5):495-501. doi: 10.1001/jamadermatol.2023.6158.
4
Long-term survival of stage IV melanoma patients: evaluation on 640 melanoma patients entering stage IV between 2014 and 2017.640 例 2014 年至 2017 年进入 IV 期的黑色素瘤患者的 IV 期黑色素瘤患者的长期生存:评估。
J Cancer Res Clin Oncol. 2024 Jan 18;150(1):15. doi: 10.1007/s00432-023-05533-0.
5
Association between pretreatment emotional distress and neoadjuvant immune checkpoint blockade response in melanoma.黑色素瘤患者治疗前情绪困扰与新辅助免疫检查点阻断反应之间的关联
Nat Med. 2023 Dec;29(12):3090-3099. doi: 10.1038/s41591-023-02631-x. Epub 2023 Nov 13.
6
Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial.辅助纳武利尤单抗治疗 IIB/C 期黑色素瘤:CheckMate 76K 随机、III 期研究的主要结果。
Nat Med. 2023 Nov;29(11):2835-2843. doi: 10.1038/s41591-023-02583-2. Epub 2023 Oct 16.
7
Global Incidence, Mortality, Risk Factors and Trends of Melanoma: A Systematic Analysis of Registries.全球黑色素瘤发病率、死亡率、风险因素和趋势:基于注册系统的系统分析。
Am J Clin Dermatol. 2023 Nov;24(6):965-975. doi: 10.1007/s40257-023-00795-3. Epub 2023 Jun 10.
8
Interplay between stress and cancer-A focus on inflammation.压力与癌症之间的相互作用——聚焦于炎症
Front Physiol. 2023 Mar 20;14:1119095. doi: 10.3389/fphys.2023.1119095. eCollection 2023.
9
Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial.帕博利珠单抗对比安慰剂作为完全切除的IIB期或IIC期黑色素瘤辅助治疗(KEYNOTE-716):一项随机、双盲、3期试验
Lancet. 2022 Apr 30;399(10336):1718-1729. doi: 10.1016/S0140-6736(22)00562-1. Epub 2022 Apr 1.
10
Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040.2020 年全球皮肤黑色素瘤负担及 2040 年预测。
JAMA Dermatol. 2022 May 1;158(5):495-503. doi: 10.1001/jamadermatol.2022.0160.